Red-blood-cell allo-immunization;Allo-immunisation anti-érythrocytaire

Transfusion Clinique et Biologique

Volumn 19, Issue 6, 2012, Pages 321-332

  Pham, B N ^a,b   Le Pennec, P Y ^a,b   Rouger, P ^a,b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Centre National de Référence Pour Les Groupes Sanguins CNRGS   (France)

Author keywords

Allo immunziation; Antibody; Blood groups; RBC

Indexed keywords

ERYTHROCYTE ANTIGEN;

ALLOIMMUNIZATION; ANTIBODY RESPONSE; ERYTHROCYTE; IMMUNE RESPONSE; SHORT SURVEY;

ANTIBODY FORMATION; ERYTHROCYTES; HUMANS; ISOANTIBODIES;

EID: 84870295151     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2012.06.007     Document Type: Short Survey

References (49)

1. Storry J.R., Castilho L., Daniels G., Flegel W.A., Garratty G., Francis C.L., et al. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011, 101:77-82.
2. Levine P., Stetson R.E. An unusual case of intra-group agglutination. J Am Med Assoc 1939, 113:126-127.
3. Walker W. The changing pattern of haemolytic disease of the newborn (1948-1957). Vox Sang 1985, 3:225-336.
4. Heddle N.M., Klama L., Frassetto R., O'Hoski P., Leaman B. A retrospective study to determine the risk of red cell allo-immunization and transfusion during pregnancy. Transfusion 1993, 33:217-220.
5. Giblett E.R. A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1961, 1:233-238.
6. Klein H.G., Anstee D.J. Mollison's blood transfusion in clinical medicine 2005, Blackwell Publishing Ltd, Massachusetts. 11th ed.
7. Schonewille H., van de Watering L.M., Loomans D.S., Brand A. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006, 46:250-256.
8. Tormey C.A., Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009, 114:4279-4282.
9. Poole J., Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007, 21:58-71.
10. Tormey C.A., Fisk J., Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008, 48:2069-2076.
11. Connolly M., Erber W.N., Grey D.E. Case report: immune anti-D stimulated by transfusion of fresh frozen plasma. Immunohematology 2005, 21:149-151.
12. Frohn C., Dümbgen L., Brand J.M., Görg S., Luhm J., Kirchner H. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003, 43:893-898.
13. Stratton F. Rapid Rh-typing: a sandwich technique. Br Med J 1955, 1:201-203.
14. Brantley S.G., Ramsey G. Red cell allo-immunization in multitransfused HLA-typed patients. Transfusion 1988, 28:463-466.
15. Ansart-Pirenne H., Zeliszewski D., Lee K., Martin-Blanc S., Rouger P., Noizat-Pirenne F. Identification of immunodominant alloreactive T-cell epitopes on the Jka red blood cell protein inducing either Th1 or Th2 cytokine expression. Blood 2004, 104:3409-3410.
16. Reviron D., Dettori I., Ferrera V., Legrand D., Touinssi M., Mercier P., et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion 2005, 45:956-959.
17. Chiaroni J., Dettori I., Ferrera V., Legrand D., Touinssi M., Mercier P., et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006, 132:374-378.
18. Picard C., Frassati C., Basire A., Buhler S., Galicher V., Ferrera V., et al. Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a Southern European population. Transfusion 2009, 49:2412-2417.
19. Rosse W.F., Gallagher D., Kinney T.R., Castro O., Dosik H., Moohr J., et al. Transfusion and allo-immunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990, 76:1431-1437.
20. Hoeltge G.A., Domen R.E., Rybicki L.A., Schaffer P.A. Multiple red cell transfusions and allo-immunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995, 119:42-45.
21. Vichinsky E.P., Earles A., Johnson R.A., Hoag M.S., Williams A., Lubin B. Allo-immunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990, 322:1617-1621.
22. Zalpuri S., Zwaginga J.J., le Cessie S., Elshuis J., Schonewille H., van der Bom J.G. Red-blood-cell allo-immunization and number of red-blood-cell transfusions. Vox Sang 2011, 102:144-149.
23. Sarnaik S., Schornack J., Lusher J.M. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986, 26:249-252.
24. Schonewille H., van de Watering L.M., Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic allo-immunized patient cohort: is it time to take precautionary measures?. Transfusion 2006, 46:630-635.
25. Higgins J.M., Sloan S.R. Stochastic modeling of human RBC allo-immunization: evidence for a distinct population of immunologic responders. Blood 2008, 112:2546-2553.
26. Issitt P.D., Anstee D.J. Antibody detection and identification and compatibility testing. In: Applied blood group serology 1998, Montgomery Scientific Publications, Durham (NC). 4th ed.
27. Redman M., Regan F., Contreras M. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 1996, 71:216-220.
28. Sirchia G., Zanella A., Parravicini A., Morelati F., Rebulla P., Masera G. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion 1985, 25:110-112.
29. Natukunda B., Schonewille H., Ndugwa C., Brand A. Red blood cell allo-immunization in sickle cell disease patients in Uganda. Transfusion 2010, 50:20-25.
30. Economidou J., Constantoulakis M., Augoustaki O., Adinolfi M. Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece. Vox Sang 1971, 20:252-258.
31. Singer S.T., Wu V., Mignacca R., Kuypers F.A., Morel P., Vichinsky E.P. Allo-immunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood 2000, 96:3369-3373.
32. Natukunda B., Brand A., Schonewille H. Red blood cell allo-immunization from an African perspective. Curr Opin Hematol 2010, 17:565-570.
33. Osby M., Shulman I.A. Phenotype matching of donor red blood cell units for nonallo-immunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005, 129:190-193.
34. Castro O., Sandler S.G., Houston-Yu P., Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion 2002, 42:684-690.
35. Yazer M.H., Triulzi D.J. Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion 2007, 47:2197-2201.
36. Gonzalez-Porras J.R., Graciani I.F., Perez-Simon J.A., Martin-Sanchez J., Encinas C., Conde M.P., et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion 2008, 48:1318-1324.
37. Petz L.D., Garratty G. Immune hemolytic anemias 2004, Churchill Livingstone, Philadelphia. 2nd ed.
38. Salmon C., Cartron J.P., Rouger P. Les groupes sanguins chez l'Homme 1990, Masson, Paris. 2e éd.
39. Bauer M.P., Wiersum-Osselton J., Schipperus M., Vandenbroucke J.P., Briët E. Clinical predictors of allo-immunization after red blood cell transfusion. Transfusion 2007, 47:2066-2071.
40. Aygun B., Padmanabhan S., Paley C., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002, 42:37-43.
41. Urbaniak S.J. Allo-immunity to human red blood cell antigens. Vox Sang 2002, 83:293-297.
42. Thompson A.A., Cunningham M.J., Singer S.T., Neufeld E.J., Vichinsky E., Yamashita R., et al. Red cell allo-immunization in a diverse population of transfused patients with thalassaemia. Br J Haematol 2011, 153:121-128.
43. Campbell-Lee S.A., Liu J., Velliquette R.W., Halverson G.R., Shirey R.S., Chaudhuri A., et al. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Transfusion 2006, 46:1682-1688.
44. Schirmer D.A., Song S.C., Baliff J.P., Harbers S.O., Clynes R.A., Krop-Watorek A., et al. Mouse models of IgG- and IgM-mediated hemolysis. Blood 2007, 109:3099-3107.
45. Hendrickson J.E., Desmarets M., Deshpande S.S., Chadwick T.E., Hillyer C.D., Roback J.D., et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006, 46:1526-1536.
46. Hudson K.E., Lin E., Hendrickson J.E., Lukacher A.E., Zimring J.C. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood 2010, 115:3989-3996.
47. Hendrickson J.E., Chadwick T.E., Roback J.D., Hillyer C.D., Zimring J.C. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007, 110:2736-2743.
48. Hendrickson J.E., Roback J.D., Hillyer C.D., Easley K.A., Zimring J.C. Discrete Toll-like receptor agonists have differential effects on allo-immunization to transfused red blood cells. Transfusion 2008, 48:1869-1877.
49. Hod E.A., Zhang N., Sokol S.A., Wojczyk B.S., Francis R.O., Ansaldi D., et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010, 115:4284-4292.